Court sides with psychedelic biotech, over hedge fund
Despite short notice to shareholders, annual meeting properly called
- By: James Langton
- January 29, 2026 January 29, 2026
- 09:22
Despite short notice to shareholders, annual meeting properly called
Man sentenced for role in laundering profits of crypto scams
Company, executives agree to settle allegations, pay US$41 million
Increase in claimed class-action damages points to larger settlements
Bill raises enforcement penalties, enables binding dispute resolution
Execs falsely inflated firm's revenues to enable acquisition, regulator charges
Previously banned advisor found guilty of six out of 10 counts
FCA review will examine expected impact of AI on retail financial markets
Awareness of transition is growing, but funding needs to follow: report
Ex-CEO misled investors over regulatory approval for new drugs
Initial sanction allowed RRSP, but he traded TFSA, margin accounts too
Panel sought alternative remedy to address disclosure concerns
Inside info acquired by snooping on client's computer, ASIC alleged
FCA consults on latest phase of new rules for crypto firms
Company to appeal denied $213M claim against flagship fund
Releases were misleading, but case against lawyer not proven, panel finds
Legal filings included citations that were made up by AI
Proposed claim alleges receiver failed to cash out of stock that hit $100 million
Proposed new investor report, cost metric not part of initial reform
Accounts opened for shell companies to funnel money to Colombia
Appeal court overturns lower court, rules death triggers vesting of will
Firm to pay $220,000 to resolve allegations of several rule breaches
Aussie regulator reports A$40 million returned to investors as part of review
Injured man sought removal of court-ordered guardian
Panel stresses "open courts" principle in denying closed door hearing